120 related articles for article (PubMed ID: 23760860)
1. Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands.
Font-Gonzalez A; Liu L; Voogd AC; Schmidt MK; Roukema JA; Coebergh JW; de Vries E; Soerjomataram I
Breast Cancer Res Treat; 2013 Jun; 139(3):811-9. PubMed ID: 23760860
[TBL] [Abstract][Full Text] [Related]
2. Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study.
Vichapat V; Garmo H; Holmqvist M; Liljegren G; Wärnberg F; Lambe M; Fornander T; Adolfsson J; Lüchtenborg M; Holmberg L
J Clin Oncol; 2012 Oct; 30(28):3478-85. PubMed ID: 22927521
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.
Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M
Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018
[TBL] [Abstract][Full Text] [Related]
4. The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy.
Abdalla I; Thisted RA; Heimann R
Cancer J; 2000; 6(4):266-72. PubMed ID: 11038147
[TBL] [Abstract][Full Text] [Related]
5. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
Schaapveld M; Visser O; Louwman WJ; Willemse PH; de Vries EG; van der Graaf WT; Otter R; Coebergh JW; van Leeuwen FE
Breast Cancer Res Treat; 2008 Jul; 110(1):189-97. PubMed ID: 17687645
[TBL] [Abstract][Full Text] [Related]
6. Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer.
Liederbach E; Wang CH; Lutfi W; Kantor O; Pesce C; Winchester DJ; Yao K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S412-21. PubMed ID: 26334294
[TBL] [Abstract][Full Text] [Related]
7. Mortality after contralateral breast cancer in Denmark.
Langballe R; Frederiksen K; Jensen MB; Andersson M; Cronin-Fenton D; Ejlertsen B; Mellemkjær L
Breast Cancer Res Treat; 2018 Sep; 171(2):489-499. PubMed ID: 29948403
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for contralateral breast cancer in Chennai (Madras), India.
Gajalakshmi CK; Shanta V; Hakama M
Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728
[TBL] [Abstract][Full Text] [Related]
9. Survival from contralateral breast cancer.
Gajalakshmi CK; Shanta V; Hakama M
Breast Cancer Res Treat; 1999 Nov; 58(2):115-22. PubMed ID: 10674875
[TBL] [Abstract][Full Text] [Related]
10. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer.
Hooning MJ; Aleman BM; Hauptmann M; Baaijens MH; Klijn JG; Noyon R; Stovall M; van Leeuwen FE
J Clin Oncol; 2008 Dec; 26(34):5561-8. PubMed ID: 18854572
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
12. Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.
Prater J; Valeri F; Korol D; Rohrmann S; Dehler S
J Cancer Res Clin Oncol; 2016 Feb; 142(2):365-71. PubMed ID: 26298838
[TBL] [Abstract][Full Text] [Related]
13. Contralateral breast cancer: clinical characteristics and impact on prognosis.
Healey EA; Cook EF; Orav EJ; Schnitt SJ; Connolly JL; Harris JR
J Clin Oncol; 1993 Aug; 11(8):1545-52. PubMed ID: 8336193
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer.
Sandberg ME; Hartman M; Klevebring D; Eloranta S; Ploner A; Hall P; Czene K
Breast Cancer Res Treat; 2012 Jul; 134(2):793-800. PubMed ID: 22622811
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association.
Majed B; Dozol A; Ribassin-Majed L; Senouci K; Asselain B
Breast Cancer Res Treat; 2011 Apr; 126(3):729-38. PubMed ID: 20872242
[TBL] [Abstract][Full Text] [Related]
16. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
17. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
[TBL] [Abstract][Full Text] [Related]
18. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of contralateral breast cancer: an overestimation of risk.
Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
[TBL] [Abstract][Full Text] [Related]
20. Are patients diagnosed with breast cancer before age 50 years ever cured?
Brenner H; Hakulinen T
J Clin Oncol; 2004 Feb; 22(3):432-8. PubMed ID: 14691121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]